Streetinsider

Published September 16, 2026

Oppenheimer sees positive outlook for psychedelics after FDA hearing - StreetInsider

Read the full story at Streetinsider

The firm expects near-term commercial launches of CMPS's COMP360, which uses psilocybin, and DFTX's DT120, which uses LSD . Future product labeling.